Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Net Income (2023 - 2025)

Historic Net Income for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$20.4 million.

  • Metagenomi's Net Income fell 862.94% to -$20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$88.7 million, marking a year-over-year decrease of 1999.08%. This contributed to the annual value of -$78.1 million for FY2024, which is 1436.23% down from last year.
  • Per Metagenomi's latest filing, its Net Income stood at -$20.4 million for Q3 2025, which was down 862.94% from -$19.9 million recorded in Q2 2025.
  • Metagenomi's 5-year Net Income high stood at -$10.7 million for Q2 2024, and its period low was -$25.1 million during Q1 2024.
  • For the 3-year period, Metagenomi's Net Income averaged around -$18.8 million, with its median value being -$19.8 million (2023).
  • Within the past 5 years, the most significant YoY rise in Metagenomi's Net Income was 1744.31% (2024), while the steepest drop was 11422.61% (2024).
  • Metagenomi's Net Income (Quarter) stood at -$19.3 million in 2023, then dropped by 21.27% to -$23.4 million in 2024, then grew by 12.84% to -$20.4 million in 2025.
  • Its Net Income stands at -$20.4 million for Q3 2025, versus -$19.9 million for Q2 2025 and -$25.0 million for Q1 2025.